Vaxart, Inc. — S-3/A Filings
10 S-3/A filings on record
This page lists all S-3/A filings submitted to the SEC by Vaxart, Inc. (VXRT), sorted by most recent first. Each row links to the full filing on EdgarLookup. Vaxart, Inc. has filed 10 S-3/A documents with the SEC since 2010. To view all SEC filings by Vaxart, Inc., see the full filings list.
All
10-C
10-K
10-K/A
10-K405
10-Q
10-Q/A
11-K
144
15-15D
25-NSE
3
3/A
4
4/A
424B1
424B2
424B3
424B4
424B5
425
5
5/A
8-A12B
8-A12G
8-K
8-K/A
ARS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFC14A
DEFM14A
DFAN14A
EFFECT
FWP
NO ACT
NT 10-K
NT 10-Q
POS AM
PRE 14A
PREC14A
PREM14A
PREN14A
PRER14A
PRRN14A
PX14A6G
REGDEX
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-I
SC TO-I/A
SCHEDULE 13G
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| S-3/A | S-3/A | 0001047469-19-001206 | Mar 14, 2019 | — |
| S-3/A | FORM S-3/A | 0001513162-18-000329 | Dec 27, 2018 | — |
| S-3/A | FORM S-3/A | 0001437749-13-012893 | Oct 9, 2013 | — |
| S-3/A | AMENDMENT NO. 1 TO FORM S-3 | 0001193125-05-147333 | Jul 22, 2005 | — |
| S-3/A | NABI BIOPHARMACEUTICALS S-3/A 333-112006 | 0000950144-04-001867 | Mar 2, 2004 | — |
| S-3/A | FORM S-3/A AMENDMENT #1 | 0001193125-03-094317 | Dec 15, 2003 | — |
| S-3/A | NABI BIOPHARMACEUTICALS S-3/A 333-107134 | 0000950144-03-011403 | Oct 9, 2003 | — |
| S-3/A | NABI BIOPHARMACEUTICALS S-3/A 333-108086 | 0000950144-03-011335 | Oct 7, 2003 | — |
| S-3/A | NABI BIOPHARMACEUTICALS | 0000950144-03-011333 | Oct 7, 2003 | — |
| S-3/A | AMENDMENT NO. 1 | 0000950109-96-002654 | May 3, 1996 | — |